Bionik Laboratories Corp. - POS AM filing on 2018-09-21

NOTES PAYABLE (Tables)

3 Months Ended

12 Months Ended

Jun. 30, 2018

Mar. 31, 2018

Convertible Debt [Table Text Block]

Balance, March 31, 2018		$	51,479
Accrued interest			1,496
Repayment			52,975
Balance, June 30, 2018		$	-

Balance, March 31, 2016		$	-
Additional principal investment			2,000,000
Accrued Interest			17,488
Balance, March 31, 2017			2,017,488
Additional principal investment			2,999,975
Fair value of warrants			(548,178	)
Accretion expense			548,178
Accrued Interest			1,037,067
Conversion of principal and interest			(6,054,530	)
Balance, March 31, 2018		$	-

Schedule of Short-term Debt [Table Text Block]

Balance, March 31, 2017		$	-
Additional principal investment			500,000
Accrued Interest			33,556
Conversion of principal and interest			(533,556	)
Balance, March 31, 2018		$	-

Schedule of Conversion of Notes Payable [Table Text Block]

		March 31, 2018
		Principal				Interest				Premium				Total Conversion Amount				Beneficial Conversion Feature				Number of Shares Converted
Convertible Notes Payable (December 2016 to December 2017)		$	4,999,975			$	1,054,555			$	1,249,994			$	7,304,523			$	762,301				116,919,141
Chinese Convertible Loan		$	500,000			$	33,556				-			$	533,556			$	76,230				9,394,346
Convertible Notes Payable (December 2017 to March 2018)		$	3,611,400			$	201,928				-			$	3,813,328			$	550,598				61,037,660
Total		$	9,111,375			$	1,290,039			$	1,249,994			$	11,651,407			$	1,389,129				187,351,147

Schedule of Convertible Debt Fair Value [Table Text Block]

		At issuance
						Conversion feature fair value												At June 30, 2018
		Principal				Beneficial conversion				Anti-dilution				Fair value of debt				Accretion expense				Interest				Ending balance
Convertible promissory note		$	2,965,971			$	368,936			$	1,042,632			$	1,554,403			$	134,251			$	3,533			$	1,692,187

Schedule of Convertible Debt Beneficial Conversion Feature Table text Block [Table Text Block]

Conversion feature fair value		Beneficial conversion				Anti-dilution				Total
At Issuance		$	368,936			$	1,042,632			$	1,411,568
Fair value adjustment			60,304				(16,217	)			44,087
Ending balance at June 30, 2018		$	429,240			$	1,026,415			$	1,455,655

Convertible Debt [Member]

Schedule of Short-term Debt [Table Text Block]

Balance, March 31, 2017			-
Additional principal investment			3,611,400
Accrued Interest			201,928
Conversion of principal and interest			(3,813,328	)
Balance, March 31, 2018		$	-

Demand Notes payable [Member]

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Balance, March 31, 2016		$	-
Acquisition of IMT (Note 4)			324,894
Accrued interest			5,706
Balance, March 31, 2017			330,600
Accrued interest			8,497
Repayment of principal			(208,359	)
Repayment of interest			(79,259	)
Balance, March 31, 2018		$	51,479

Promissory Note [Member]

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Balance, March 31, 2016		$	-
Acquisition of IMT			217,808
Accrued Interest			18,740
Balance, March 31, 2017			236,548
Accrued interest			12,957
Repayment of principal			(200,000	)
Repayment of interest			(49,505	)
Balance, March 31, 2018		$	-